Altimmune, Inc.
ALT News Today: Stay Updated with the Latest Altimmune, Inc. News in Real Time
Find ALT news now at Meyka AI. Stay informed with the latest Altimmune, Inc. stocks updates, including price news, market analysis, and expert insights.
HWM Earnings Preview: Howmet Aerospace May 7 Report
Howmet Aerospace earnings preview: $1.11 EPS and $2.24B revenue expected May 7. Analyst consensus and what to watch.
STIXD Stock Surges 37,500% Volume on May 6, 2026
STIXD stock trades at $0.0001 on PNK with massive 75,000 share volume spike. Semantix Inc. data platform faces steep challenges.
CZWI Director Olson Buys 1,000 Shares on May 06, 2026
Citizens Community Bancorp director Timothy Olson purchased 1,000 shares at $20.95 on May 5, 2026. Insider buying signal.
FSLR.SW Stock Surges 144% on Massive Volume Spike, May 6
FSLR.SW stock jumps 144% to CHF153.4 on SIX with extreme volume spike of 120 shares. First Solar analysis inside.
GILD Earnings Preview: Gilead Sciences Q1 2026 on May 7
Gilead Sciences earnings preview: Analysts expect $1.89 EPS and $6.91B revenue on May 7, 2026. Historical beat pattern suggests upside potential.
GILD Earnings Preview: Gilead Sciences Q1 2026 on May 7
Gilead Sciences earnings preview for May 7, 2026. Analysts expect $1.89 EPS and $6.91B revenue. Historical beat/miss analysis inside.
ETSY Chief Product Officer Sells 4,776 Shares on May 04, 2026
Etsy Chief Product Officer Richard Colburn sold 4,776 shares at $65.09 per share on May 04, 2026, totaling $310,869.84.
Bajaj Auto Q4 Results Preview: Revenue and Profit May Post Double-Digit Growth
Bajaj Auto is expected to announce its Q4 FY26 results on May 6, 2026. Early estimates suggest strong double-digit growth in both revenue and profit. The company has benefited from steady demand in motorcycles and rising exports across key markets. Analysts also point to better pricing and premium models driving performance. Investors are now watching…
ZOE.DE Zoetis Q1 2026 Earnings Preview – May 7
Zoetis Q1 2026 earnings preview: $1.39 EPS and $1.99B revenue expected. Animal health leader faces valuation pressure.